Log in to save to my catalogue

Galectin‐3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predicto...

Galectin‐3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predicto...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01abd711c31e459c956a6dd6c63fa5f2

Galectin‐3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predictors of cardiac fibrosis development in sport

About this item

Full title

Galectin‐3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predictors of cardiac fibrosis development in sport

Author / Creator

Publisher

England: John Wiley & Sons, Inc

Journal title

Experimental physiology, 2023-10, Vol.108 (10), p.1257-1258

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

According to recent research, ST2 is a new biomarker for predicting heart failure. [...]recent studies have highlighted that repeated bouts of acute, high-intensity exercise lead to deleterious changes in heart tissue that may manifest as an abrupt change in cardiac biomarkers, and ST2 and Gal-3 may thus provide significant information (Le Goff et...

Alternative Titles

Full title

Galectin‐3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predictors of cardiac fibrosis development in sport

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_01abd711c31e459c956a6dd6c63fa5f2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01abd711c31e459c956a6dd6c63fa5f2

Other Identifiers

ISSN

0958-0670,1469-445X

E-ISSN

1469-445X

DOI

10.1113/EP091428

How to access this item